Phase III Double-blind Randomized Placebo Controlled Trial of Atezolizumab in Combination With Paclitaxel and Carboplatin in Women With Advanced/Recurrent Endometrial Cancer
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2019
Price : $35 *
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Carcinoma; Endometrial cancer
- Focus Therapeutic Use
- Acronyms AtTEnd
- 04 Jun 2019 Trial design presented at the 55th Annual Meeting of the American Society of Clinical Oncology.
- 06 Nov 2018 Status changed from not yet recruiting to recruiting.
- 05 Sep 2018 Planned initiation date changed from 1 Jul 2018 to 1 Sep 2018.